Concepedia
Statistics
Publications
4
Citations
120
H-Index
Active since
1998
Affiliations
Marien Hospital Witten(Current)
Ludwig-Maximilians-Universität München
R Kates is an author at Marien Hospital Witten specializing in medicine, oncology, and pharmacology.
Publications per year
1998–2024
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
Ellen Warner, David W. Hedley, Irene L. Andrulis et al. · PubMed · 1998 · 48 citations
Medicine, Oncology, Pharmacology +17
Abstract S5-03: Final analysis of WSG-ADAPT HER2+/HR+ phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant TDM1 with or without endocrine therapy versus trastuzumab+endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer
Nadia Harbeck, Oleg Gluz, Matthias Christgen et al. · Cancer Research · 2016 · 29 citations
Medicine, Pharmacology, Pharmacotherapy +17
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy
M. Martín, S.R. Stecklein, Oleg Gluz et al. · Annals of Oncology · 2024 · 27 citations · Full text
Medicine, Bioinformatics, Oncology +16
Abstract S6-07: Comparison of 12 weeks neoadjuvant Nab-paclitaxel combined with carboplatinum vs. gemcitabine in triple- negative breast cancer: WSG-ADAPT TN randomized phase II trial
Oleg Gluz, Ulrike Nitz, C Liedtke et al. · Cancer Research · 2016 · 16 citations
1–4 of 4